Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Return on Equity (2020 - 2025)

Celularity has reported Return on Equity over the past 6 years, most recently at 3.54% for Q3 2025.

  • Quarterly results put Return on Equity at 3.54% for Q3 2025, up 509.0% from a year ago — trailing twelve months through Sep 2025 was 3.54% (up 509.0% YoY), and the annual figure for FY2024 was 2.33%, down 69.0%.
  • Return on Equity for Q3 2025 was 3.54% at Celularity, down from 4.75% in the prior quarter.
  • Over the last five years, Return on Equity for CELU hit a ceiling of 4.75% in Q2 2025 and a floor of 33.4% in Q1 2025.
  • Median Return on Equity over the past 5 years was 0.6% (2023), compared with a mean of 2.55%.
  • Peak annual rise in Return on Equity hit 857bps in 2025, while the deepest fall reached -2913bps in 2025.
  • Celularity's Return on Equity stood at 1.02% in 2021, then soared by 108bps to 0.08% in 2022, then crashed by -7154bps to 5.51% in 2023, then increased by 20bps to 4.43% in 2024, then skyrocketed by 180bps to 3.54% in 2025.
  • The last three reported values for Return on Equity were 3.54% (Q3 2025), 4.75% (Q2 2025), and 33.4% (Q1 2025) per Business Quant data.